Mindray Signs Agreement With Novation
Mindray Medical International Limited (NYSE: MR) today announced that it has entered into an agreement with Novation allowing its more than 65,000 members and affiliates to purchase Mindray's M7 and M5 ultrasound systems.
"We are pleased to enter into this agreement with Novation and look forward to partnering with the members it serves in supplying state-of-the-art ultrasound technology," said Michael Thompson, Vice President of Ultrasound Sales, Mindray North America. "Now these members can take advantage of Mindray's upgradeable architecture, which provides a significant price-to-value ratio.
"Mindray has been widely noted for its high-quality imaging and innovation over the years. Both the M7 and M5 systems can be used in a wide array of clinical applications. In addition, each system comes with numerous choices of transducers and options. We look forward to helping Novation's members find the right solutions for every facility's specific imaging needs," Thompson added.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.